10 Mai 2023 | News
Last month Technophage team attended 33rd European Congress of Clinical Microbiology & Infectious Diseases with the clinical team from Israel, and Dr. Ran Nir-Paz from Hadassah Medical Center, presented the results obtained in the Phase I/IIa double-blinded,...
8 Mai 2023 | News
Technophage has been featured in ‘The Economist’ journal. The piece entitled ‘Western firms are becoming interested in a Soviet medicine’ describes how phage therapy is helping patients around the globe, highlighting the increased interest of western...
5 Mai 2023 | News
In the scope of the “Visit of delegation led by Chief Executive of Macao SAR and University of Macau Delegation to the University of Lisbon”, Technophage was invited to present the work that has been developed since 2014 in collaboration with the University of Macau....
5 Mai 2023 | News
Last month Technophage team attended ECCMID 2023, and together with the clinical team from Israel, we have presented the results from two cases of compassionate use carried out in Israel, under the supervision of Dra. Michal Deckel. – Case study 1 showed a...
15 Mar 2023 | News
TechnoPhage is currently working on several projects in different therapeutic areas, such as infection, ophthalmology, or neuroscience, among which numerous patents have been placed throughout the years. Did you know that the total number of ‘live’ patents...
25 Nov 2022 | News
This year Technophage has been featured in the Portuguese edition of The Business Year. The publication was based on more than 130 face-to-face interviews with leading #investors, business leaders, and government representatives from all the key sectors driving...
